Alpha Teknova Inc (TKNO)

Currency in USD
3.890
+0.020(+0.52%)
Closed·
3.8900.000(0.00%)
·
TKNO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.8454.050
52 wk Range
1.9106.680
Key Statistics
Prev. Close
3.87
Open
3.91
Day's Range
3.845-4.05
52 wk Range
1.91-6.68
Volume
134.03K
Average Volume (3m)
127.06K
1-Year Change
-34.8409%
Book Value / Share
1.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TKNO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.000
Upside
+131.36%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Alpha Teknova Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 9.000
(+131.36% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Hold---MaintainMay 14, 2026
Stephens
Buy8.00+105.66%-New CoverageJul 22, 2025

Alpha Teknova Inc Earnings Call Summary for Q1/2026

  • Alpha Teknova reported Q1 2026 revenue of $11M, up 13% YoY, marking highest Q1 revenue in nearly three years with improved gross margin of 34.2%.
  • Net loss held steady at $4.6M while EPS improved to $(0.08) from $(0.09); adjusted EBITDA improved $0.5M YoY to $(2.0)M loss.
  • Stock declined 2.67% to $3.74 in regular trading despite strong results, down 39% over past year; slight 0.27% aftermarket recovery observed.
  • Company reaffirmed 2026 revenue guidance of $42M-$44M with mid-30% gross margins; expects EBITDA profitability at $52M-$57M annualized revenue.
  • Management cited strategic investments in Lab Essentials and Clinical Solutions segments; profitability timeline depends on market conditions strengthening in 2027.
Last Updated: 2026-05-06, 07:16 p/m
Read Full Transcript

Earnings

Latest Release
May 07, 2026
EPS / Forecast
-0.08 / -0.09
Revenue / Forecast
11.07M / 10.19M
EPS Revisions
Last 90 days

TKNO Income Statement

Compare TKNO to Peers and Sector

Metrics to compare
TKNO
Peers
Sector
Relationship
P/E Ratio
−12.1x−4.5x−0.5x
PEG Ratio
−0.37−0.090.00
Price/Book
3.2x1.1x2.6x
Price / LTM Sales
5.0x3.0x3.1x
Upside (Analyst Target)
116.2%53.1%53.0%
Fair Value Upside
Unlock15.9%6.3%Unlock

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company’ primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.92M3.58%7.42M
Other Institutional Investors
82.02M96.42%317.42M
Public Companies & Retail Investors
0.000.00%0.00
Total
83.94M100.00%324.84M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Telegraph Hill Partners70.35%37,717,565146,721
Telegraph Hill Partners IV, L.P.49.60%26,590,636103,438

People Also Watch

3.260
TLSI
-5.51%
23.99
NECB
-0.62%
4.9
POCI
0.00%
5.71
WEAV
+1.78%
14.88
ANIK
-0.93%

FAQ

What Is the Alpha Teknova (TKNO) Stock Price Today?

The Alpha Teknova stock price today is 3.890 USD.

What Stock Exchange Does Alpha Teknova Trade On?

Alpha Teknova is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Alpha Teknova?

The stock symbol for Alpha Teknova is "TKNO."

What Is the Alpha Teknova Market Cap?

As of today, Alpha Teknova market cap is 208.560M USD.

What Is Alpha Teknova's Earnings Per Share (TTM)?

The Alpha Teknova EPS (TTM) is -0.321.

When Is the Next Alpha Teknova Earnings Date?

Alpha Teknova will release its next earnings report on Aug 12, 2026.

From a Technical Analysis Perspective, Is TKNO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Alpha Teknova Stock Split?

Alpha Teknova has split 0 times.

How Many Employees Does Alpha Teknova Have?

Alpha Teknova has 158 employees.

What is the current trading status of Alpha Teknova (TKNO)?

As of May 23, 2026, Alpha Teknova (TKNO) is trading at a price of 3.890 USD, with a previous close of 3.870 USD. The stock has fluctuated within a day range of 3.845 USD to 4.050 USD, while its 52-week range spans from 1.910 USD to 6.680 USD.

What Is Alpha Teknova (TKNO) Price Target According to Analysts?

The average 12-month price target for Alpha Teknova is 9.000 USD, with a high estimate of 12 USD and a low estimate of 7 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +131.36% Upside potential.

What Is the TKNO Premarket Price?

TKNO's last pre-market stock price is 3.466 USD. The pre-market share volume is 1,200.000, and the stock has decreased by -0.404, or -10.440%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.